Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • iCo ophthalmic, autoimmune, infectious news

    iCo Therapeutics Inc. (TSX-V:ICO; OTCQX:ICOTF), Vancouver, B.C. Business: Ophthalmic, Autoimmune, Infectious iCo terminated all employees to preserve cash. In 2014, iCo reported that iCo-007 failed in a Phase II trial …

    Published on 2/8/2016
  • Kymab, Regeneron antibodies news

    Kymab Ltd., Cambridge, U.K. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Business: Antibodies Kymab said the English High Court invalidated EU Patents Nos. EP1360287 and EP2264163 from Regeneron …

    Published on 2/8/2016
  • Sosei, Imperial College London inflammation, autoimmune news

    Sosei Group Corp. (Tokyo:4565), Tokyo, Japan Imperial College London, London, U.K. Business: Inflammation, Autoimmune Soseis Heptares Therapeutics Ltd. subsidiary is committing up to L5 million ($7.1 million) over the …

    Published on 2/8/2016
  • Nuo Therapeutics dermatology news

    Nuo Therapeutics Inc. (OTCQX:NUOT), Gaithersburg, Md. Business: Dermatology Nuo filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. The company markets its Aurix System in the U.S.…

    Published on 2/1/2016
  • Amgen, AbbVie autoimmune news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Business: Autoimmune The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (PTO) denied two inter …

    Published on 1/25/2016
  • Merck neurology news

    Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Neurology Merck will pay $830 million plus approved attorneys fees and expenses to settle a multidistrict class action lawsuit pending in New Jersey federal court …

    Published on 1/25/2016
  • PharmAthene, Siga infectious news

    PharmAthene Inc. (NYSE-M:PIP), Annapolis, Md. Siga Technologies Inc. (Pink:SIGAQ), New York, N.Y. Business: Infectious The Delaware Supreme Court affirmed a January 2015 Court of Chancery ruling ordering Siga to pay …

    Published on 1/25/2016
  • Chimeric Therapeutics, Cancer Research UK, Cell Therapy Catapult, University of Birmingham cancer, gene/cell therapy news

    Chimeric Therapeutics Ltd., London, U.K. Cancer Research UK, London, U.K. Cell Therapy Catapult, London, U.K. University of Birmingham, Birmingham, U.K. Business: Cancer, Gene/Cell therapy Cancer Research UKs Cancer …

    Published on 1/18/2016
  • General Electric, Federal Economic Development Agency for Southern Ontario, CCRM biomanufacturing, gene/cell therapy news

    General Electric Co. (NYSE:GE), Fairfield, Conn. Federal Economic Development Agency for Southern Ontario (FedDev Ontario), Waterloo, Ontario Centre for Commercialization of Regenerative Medicine (CCRM), Toronto, …

    Published on 1/18/2016
  • Moderna Therapeutics, Valera, Bill & Melinda Gates Foundation infectious news

    Moderna Therapeutics Inc., Cambridge, Mass. Valera LLC, Cambridge, Mass. Bill & Melinda Gates Foundation, Seattle, Wash. Business: Infectious Modernas Valera LLC company will receive up to $20 million in grant funding…

    Published on 1/18/2016
  • Repros endocrine/metabolic news

    Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Business: Endocrine/Metabolic The U.S. Court of Appeals for the Federal Circuit (CAFC) upheld a district court decision that Dr. Harry Fisch, a urologist and …

    Published on 1/18/2016
  • Sequenom diagnostic, supply/service news

    Sequenom Inc. (NASDAQ:SQNM), San Diego, Calif. Business: Diagnostic, Supply/Service Sequenom said it will reduce headcount by about 110 (20%) to about 390 and restructure to focus on womens health, including R&D …

    Published on 1/18/2016
  • Caribou Biosciences, CRISPR Therapeutics, Editas Medicines Inc., Intellia Therapeutics, Broad Institute, University of California Berkeley, University of Vienna genomics news

    Caribou Biosciences Inc., Berkeley, Calif. CRISPR Therapeutics AG, Basel, Switzerland Editas Medicines Inc., Cambridge, Mass. Intellia Therapeutics Inc., Cambridge, Mass. Broad Institute of MIT and Harvard, Cambridge, …

    Published on 1/11/2016
  • Glenmark, Roche cancer news

    Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK; BSE:532296), Mumbai, India Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer Glenmark and Roche confirmed that they settled a patent dispute in India related …

    Published on 1/11/2016
  • KaloBios cancer news

    KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. Business: Cancer KaloBios filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. Earlier in December, the …

    Published on 1/4/2016
  • StemCells neurology, gene/cell therapy news

    StemCells Inc. (NASDAQ:STEM), Newark, Calif. Business: Neurology, Gene/Cell therapy StemCells will reduce headcount by 17 (about 23%) to 57 to focus resources on developing human neural stem cells (HuCNS-SC) to treat …

    Published on 1/4/2016
  • Threshold cancer news

    Threshold Pharmaceuticals Inc. (NASDAQ:THLD), South San Francisco, Calif. Business: Cancer Threshold will reduce headcount by about 66% to 20-25 to focus resources on two ongoing Phase II trials of tarloxotinib (TH-4000…

    Published on 1/4/2016
  • Turing Pharmaceuticals infectious, neurology news

    Turing Pharmaceuticals AG, Zug, Switzerland Business: Infectious, Neurology Turing will reduce headcount to streamline operations. In December, Martin Shkreli resigned as CEO after the FBI arrested him on securities …

    Published on 1/4/2016
  • Pairnomix genomics news

    Pairnomix LLC, Maple Grove, Minn. Business: Genomics Personalized genetics research company Pairnomix will launch in 2016. The company will initially focus on epilepsy and disorders of the CNS. Pairnomix plans to review…

    Published on 12/21/2015
  • Sequenom, Roche diagnostic news

    Sequenom Inc. (NASDAQ:SQNM), San Diego, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic The U.S. Court of Appeals for the Federal Circuit (CAFC) denied Sequenoms petition for en banc re-…

    Published on 12/21/2015
  • Amgen, Apotex hematology, biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Apotex Inc., Toronto, Ontario Business: Hematology, Biosimilars The U.S. District Court for the Southern District of Florida granted a preliminary injunction barring …

    Published on 12/14/2015
  • Miraculins diagnostic news

    Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic Miraculins board began a strategic review and will consider various strategic alternatives, including a revised business plan, a merger, sale or …

    Published on 12/14/2015
  • NovaBay ophthalmic news

    NovaBay Pharmaceuticals Inc. (NYSE-M:NBY), Emeryville, Calif. Business: Ophthalmic NovaBay will restructure to reduce operating expenses and focus on the commercialization of Avenova lid and lash cleanser. Mark …

    Published on 12/14/2015
  • The Foundation for AIDS Research infectious news

    The Foundation for AIDS Research, New York, N.Y. Business: Infectious The Foundation for AIDS Research (amfAR) formed the amfAR Institute for HIV Cure Research at the University of California San Francisco (San …

    Published on 12/7/2015
  • Celgene, Hayman Capital Management cancer news

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Hayman Capital Management, Dallas, Texas Business: Cancer The Patent Trial and Appeals Board (PTAB) of the U.S. Patent and Trademark Office denied an inter partes review (IPR) …

    Published on 11/23/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993